Counterfeit Drugs
2005-11-04T06:23:54-05:00https://ximage.c-spanvideo.org/eyJidWNrZXQiOiJwaWN0dXJlcy5jLXNwYW52aWRlby5vcmciLCJrZXkiOiJGaWxlc1wvOTVhXC8xODk2ODItbS5qcGciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY292ZXIiLCJoZWlnaHQiOjUwNn19fQ==Subcommittee members held a hearing title “Sick Crime: Counterfeit Drugs in the United States.” FDA officials, drug industry representatives, and family members of counterfeit drug victims testified how counterfeit drugs enter the legitimate pharmaceutical market. Among the topics members of the panels spoke about were government regulation of the drug supply line, paper pedigrees, and criminal invesigations.
During the first panel, Commissioner Lutter spoke about implementations of stringent license requirements on the state level. He discussed the use of electronic devices and new technologies in the distribution of pharmaceuticals. The second panel talked about Carlos Luis, who bought Epogen and Procrit from a gentleman’s club in Miami. He moved the drugs into the wholesale market and the family of Tim Fagan sued a CVS subdiary for distributing Epogen, an anemia drug, after his emergency liver transplant. The third panel spoke about the growth of counterfeit drugs, accreditati
During the first panel, Commissioner Lutter spoke about implementations of stringent license requirements on the state level. He discussed the use of electronic devices and new technologies in the distribution of pharmaceuticals. The second panel talked about Carlos Luis, who bought Epogen and Procrit from a gentleman’s club in Miami. He moved the drugs into the wholesale market and the family of Tim Fagan sued a CVS subdiary for distributing Epogen, an anemia drug, after his emergency liver transplant. The third panel spoke about the growth of counterfeit drugs, accreditati
Subcommittee members held a hearing title “Sick Crime: Counterfeit Drugs in the United States.” FDA officials, drug industry representatives, and… read more
Subcommittee members held a hearing title “Sick Crime: Counterfeit Drugs in the United States.” FDA officials, drug industry representatives, and family members of counterfeit drug victims testified how counterfeit drugs enter the legitimate pharmaceutical market. Among the topics members of the panels spoke about were government regulation of the drug supply line, paper pedigrees, and criminal invesigations.
During the first panel, Commissioner Lutter spoke about implementations of stringent license requirements on the state level. He discussed the use of electronic devices and new technologies in the distribution of pharmaceuticals. The second panel talked about Carlos Luis, who bought Epogen and Procrit from a gentleman’s club in Miami. He moved the drugs into the wholesale market and the family of Tim Fagan sued a CVS subdiary for distributing Epogen, an anemia drug, after his emergency liver transplant. The third panel spoke about the growth of counterfeit drugs, accreditati close
People in this video
-
-
Max Butler Brother
-
-
-
Jim Dahl Assistant Director (Former) U.S. Food and Drug Administration->Office of Criminal Investigations
-
Donald DeKieffer Attorney
-
Katherine Eban Correspondent
-
Kevin Fagan Father
-
-
-
Randall Lutter Associate Commissioner (Acting) U.S. Food and Drug Administration->Policy and Planning
-
-
-
-
-
Hosting Organization
Purchase a Download
Counterfeit Drugs
-
MP4 video - Standard
- Price:
- $9.99 or Free with MyC‑SPAN
-
MP3 audio - Standard
- Price:
- $0.99
Related Video
-
Dangerous Doses: Contaminating America's Drug Supply
Katherine Eban talked about her book Dangerous Doses: How Counterfeiters Are Contaminating America’s Drug Supply,…
-
Food and Drug Administration Approval Process
The House Government Reform Committee held a hearing on the Food and Drug Administration’s approval process for…
-
RU-486 Health and Safety Standards
Witnesses testified about the safety record of the abortion-inducing drug RU-486 and standards for women’s health…
-
FDA Oversight
Anna Edney talked about the responsibilities of the Food and Drug Administration (FDA) and the role of Congressional…